Relation of Response to Treatment with Dorzolamide in X-Linked Retinoschisis to the Mechanism of Functional Loss in Retinoschisin

American Journal of Ophthalmology

Volumn 147, Issue 1, 2009, Pages

  Walia, Saloni ^a   Fishman, Gerald A ^a   Molday, Robert S ^b   Dyka, Frank M ^b   Kumar, Nalin M ^a   Ehlinger, Mary A ^c   Stone, Edwin M ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DORZOLAMIDE; EYE DROPS; GENE PRODUCT; RETINOSCHISIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; GENE MUTATION; HUMAN; HUMAN CELL; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RETINA FOVEA; RETINOSCHISIS; RETROSPECTIVE STUDY; TREATMENT RESPONSE; X CHROMOSOME LINKED DISORDER; X LINKED RETINOSCHISIS;

EID: 57549105495     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.07.041     Document Type: Article

References (23)

1. Forsius H., Krause U., Helve J., et al. Visual acuity in 183 cases of X-chromosomal retinoschisis. Can J Ophthalmol 8 (1973) 385-393
2. Sieving P.A., Yashar B.M., and Ayyagari R. Juvenile retinoschisis: a model for molecular diagnostic testing of X-linked ophthalmic disease. Trans Am Ophthalmol Soc 97 (1999) 451-464
3. Gao H., Kusumi R., and Yung C.W. Optical coherence tomographic findings in X-linked juvenile retinoschisis. Arch Ophthalmol 123 (2005) 1006-1008
4. Apushkin M.A., Fishman G.A., and Janowicz M.J. Correlation of optical coherence tomography findings with visual acuity and macular lesions in patients with X-linked retinoschisis. Ophthalmology 112 (2005) 495-501
5. Deutman A.F. Sex-linked juvenile retinoschisis. In: Deutman A.F. (Ed). The Hereditary Dystrophies of the Posterior Pole of the Eye (1971), Van Gorcum, Assen, The Netherlands 48-98
6. George N.D., Yates J.R., and Moore A.T. X-linked retinoschisis. Br J Ophthalmol 79 (1995) 697-702
7. Roesch M.T., Ewing C.C., Gibson A.E., and Weber B.H. The natural history of X-linked retinoschisis. Can J Ophthalmol 33 (1998) 149-158
8. Sauer C.G., Gehrig A., Warneke-Wittstock R., et al. Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet 17 (1997) 164-170
9. Molday R.S. Focus on molecules: retinoschisin (RS1). Exp Eye Res 84 (2007) 227-228
10. Weber B.H., Schrewe H., Molday L.L., et al. Inactivation of the murine X-linked juvenile retinoschisis gene, RS1h, suggests a role of retinoschisin in retinal cell layer organization and synaptic structure. Proc Natl Acad Sci U S A 99 (2002) 6222-6227
11. Wu W.W., and Molday R.S. Defective discoidin domain structure, subunit assembly, and endoplasmic reticulum processing of retinoschisin are primary mechanisms responsible for X-linked retinoschisis. J Biol Chem 278 (2003) 28139-28146
12. Wang T., Waters C.T., Rothman A.M., Jakins T.J., Römisch K., and Trump D. Intracellular retention of mutant retinoschisin is the pathological mechanism underlying X-linked retinoschisis. Hum Mol Genet 11 (2002) 3097-3105
13. Wang T., Zhou A., Waters C.T., O'Connor E., Read R.J., and Trump D. Molecular pathology of X-linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisation. Br J Ophthalmol 90 (2006) 81-86
14. Dyka F.M., and Molday R.S. Coexpression and interaction of wild-type and missense RS1 mutants associated with X-linked retinoschisis: its relevance to gene therapy. Invest Ophthalmol Vis Sci 48 (2007) 2491-2497
15. Molday L.L., Wu W.W., and Molday R.S. Retinoschisin (RS1), the protein encoded by the X-linked retinoschisis gene, is anchored to the surface of retinal photoreceptor and bipolar cells through its interactions with a Na/K ATPase-SARM1 complex. J Biol Chem 282 (2007) 32792-32801
16. Apushkin M.A., and Fishman G.A. Use of dorzolamide for patients with X-linked retinoschisis. Retina 26 (2006) 741-745
17. Ghajarnia M., and Gorin M.B. Acetazolamide in the treatment of X-linked retinoschisis maculopathy. Arch Ophthalmol 125 (2007) 571-573
18. Hayashi T., Omoto S., Takeuchi T., Kozaki K., Ueoka Y., and Kitahara K. Four Japanese male patients with juvenile retinoschisis: only three have mutations in the RS1 gene. Am J Ophthalmol 138 (2004) 788-798
19. Wolfensberger T.J., Mahieu I., Jarvis-Evans J., et al. Membrane-bound carbonic anhydrase in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 35 (1994) 3401-3407
20. Wistrand P.J., Schenholm M., and Lonnerholm G. Carbonic anhydrase isoenzymes CA I and CA II in the human eye. Invest Ophthalmol Vis Sci 27 (1986) 419-428
21. Ochrietor J.D., Clamp M.F., Moroz T.P., et al. Carbonic anhydrase XIV identified as the membrane CA in mouse retina: strong expression in Müller cells and the RPE. Exp Eye Res 81 (2005) 492-500
22. Wolfensberger T.J. The role of carbonic anhydrase inhibitors in the management of macular edema. Doc Ophthalmol 97 (1999) 387-397
23. Grunwald J.E., Mathur S., and DuPont J. Effects of dorzolamide hydrochloride 2% on the retinal circulation. Acta Ophthalmol Scand 75 (1997) 236-238